← Leaderboards
Laura D Attardi
Stanford University
$23,311,175
Attributed
$25,086,612
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,115,550 · 12
By mechanism
P01$12,090,139 · 3
R35$10,644,018 · 1
R01$6,224,976 · 3
T32$4,953,776 · 1
R21$771,064 · 2
P30$269,847 · 1
Top collaborators
- Julien Sage8 shared
- Seung K Kim5 shared
Most similar at Stanford University
Same institution · by research overlap
- Dmitri A Petrov$15,352,591
- Rona G Giffard$16,158,126
- Joseph Steven Lipsick$10,255,196
- Masayuki Yazawa$6,289,286
- Rui Tang$806,550
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsPathway InteractionsInsightTumorProgramsGeneticCellsMouse ModelTumor Suppressor ProteinsMolecularCarcinogenesisMutationMutantAffectIn VivoMediatingPlayBaseCancer CellTp53 GeneMutateMalignant Neoplasm Of PancreasGenesResponse
Grant awards (63)
Pancreatic Cancer Development: Genetic and Immune Regulation$2,023,000
P01 · FY2025 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$959,618
R35 · FY2025 · CA · contact PI
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation$417,810
P01 · FY2025 · CA · contact PI
Leveraging innovative technologies in basic and clinical cancer research$395,249
T32 · FY2025 · CA · contact PI
Cancer Biology and Cancer Stem Cells$169,872
P30 · FY2025 · CA · contact PI
Pancreatic Cancer Development: Genetic and Immune Regulation$1,921,851
P01 · FY2024 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$879,804
R35 · FY2024 · CA · contact PI
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation$396,921
P01 · FY2024 · CA · contact PI
Leveraging innovative technologies in basic and clinical cancer research$395,193
T32 · FY2024 · CA · contact PI
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$119,148
R35 · FY2024 · CA · contact PI
Cancer Biology and Cancer Stem Cells$33,325
P30 · FY2024 · CA · contact PI
Pancreatic Cancer Development: Genetic and Immune Regulation$1,982,541
P01 · FY2023 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$937,837
R35 · FY2023 · CA · contact PI
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation$409,455
P01 · FY2023 · CA · contact PI
Leveraging innovative technologies in basic and clinical cancer research$406,309
T32 · FY2023 · CA · contact PI
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$125,479
R35 · FY2023 · CA · contact PI
Cancer Biology and Cancer Stem Cells$33,325
P30 · FY2023 · CA · contact PI
Pancreatic Cancer Development: Genetic and Immune Regulation$1,972,084
P01 · FY2022 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$955,710
R35 · FY2022 · CA · contact PI
Cancer Etiology, Prevention, Detection and Diagnosis$499,634
T32 · FY2022 · CA · contact PI
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation$398,988
P01 · FY2022 · CA · contact PI
Cancer Biology and Cancer Stem Cells$33,325
P30 · FY2022 · CA · contact PI
Pancreatic Cancer Development: Genetic and Immune Regulation$2,129,462
P01 · FY2021 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$974,343
R35 · FY2021 · CA · contact PI
Cancer Etiology, Prevention, Detection and Diagnosis$466,869
T32 · FY2021 · CA · contact PI
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation$438,027
P01 · FY2021 · CA · contact PI
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$981,304
R35 · FY2020 · CA · contact PI
Cancer Etiology, Prevention, Detection and Diagnosis$459,486
T32 · FY2020 · CA · contact PI
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$949,950
R35 · FY2019 · CA · contact PI
Cancer Etiology, Prevention, Detection and Diagnosis$479,110
T32 · FY2019 · CA · contact PI
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$977,640
R35 · FY2018 · CA · contact PI
Cancer Etiology, Prevention, Detection and Diagnosis$449,025
T32 · FY2018 · CA · contact PI
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$975,963
R35 · FY2017 · CA · contact PI
Cancer Etiology, Prevention, Detection and Diagnosis$722,431
T32 · FY2017 · CA · contact PI
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$974,380
R35 · FY2016 · CA · contact PI
Cancer Etiology, Prevention, Detection and Diagnosis$680,470
T32 · FY2016 · CA · contact PI
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis$832,842
R35 · FY2015 · CA · contact PI
Mouse Models to Dissect p53 Tumor Suppressor Function$344,875
R01 · FY2015 · CA · contact PI
Mouse Models to Dissect p53 Tumor Suppressor Function$333,902
R01 · FY2014 · CA · contact PI
Mouse Models to Dissect p53 Tumor Suppressor Function$322,984
R01 · FY2013 · CA · contact PI
Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio$194,763
R21 · FY2013 · CA · contact PI
Mouse Models to Dissect p53 Tumor Suppressor Function$342,990
R01 · FY2012 · CA · contact PI
Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio$172,957
R21 · FY2012 · CA · contact PI
Mouse Models to Dissect p53 Tumor Suppressor Function$342,415
R01 · FY2011 · CA · contact PI
Characterization of the Desmosome Protein Perp$328,890
R01 · FY2011 · AR · contact PI
Characterization of the p53 Apoptotic Target Gene Perp$276,291
R01 · FY2011 · CA · contact PI
Characterization of the Desmosome Protein Perp$341,804
R01 · FY2010 · AR · contact PI
Characterization of the p53 Apoptotic Target Gene Perp$284,630
R01 · FY2010 · CA · contact PI
Using p53 Knock-In Mice to Understand p53's Role in Pancreatic Cancer$219,494
R21 · FY2010 · CA · contact PI
Characterization of the Desmosome Protein Perp$342,772
R01 · FY2009 · AR · contact PI
Characterization of the p53 Apoptotic Target Gene Perp$284,434
R01 · FY2009 · CA · contact PI
Using p53 Knock-In Mice to Understand p53's Role in Pancreatic Cancer$183,850
R21 · FY2009 · CA · contact PI
Characterization of the Desmosome Protein Perp$339,907
R01 · FY2008 · AR · contact PI
Characterization of the p53 Apoptotic Target Gene Perp$284,246
R01 · FY2008 · CA · contact PI
Characterization of Siva in Nervous System Development and Apoptosis$81,056
R03 · FY2008 · NS · contact PI
Characterization of the Desmosome Protein Perp$346,330
R01 · FY2007 · AR · contact PI
Characterization of the p53 Apoptotic Target Gene Perp$283,177
R01 · FY2007 · CA · contact PI
Characterization of Siva in Nervous System Development and Apoptosis$80,674
R03 · FY2007 · NS · contact PI
Characterization of the p53 Apoptotic Target Gene PERP$281,840
R01 · FY2006 · CA · contact PI
Characterization of the p53 Apoptotic Target Gene PERP$288,270
R01 · FY2005 · CA
Characterization of the p53 Apoptotic Target Gene PERP$287,931
R01 · FY2004 · CA
Characterization of the p53 Apoptotic Target Gene PERP$287,605
R01 · FY2003 · CA
Characterization of the p53 Apoptotic Target Gene PERP$279,683
R01 · FY2002 · CA